Camilla Speziani

3rd Annual Meeting, Genoa June 2025

The annual meeting of the PerSAIDs project was successfully concluded at the splendid location of Villa Quartara, Training Center of the G. Gaslini Institute (June 26-27). The PerSAIDs Project, funded by the Ministry of Health under the ERA PerMed initiatives, focuses on pediatric systemic autoinflammatory diseases, developing innovative strategies for early diagnosis and personalized treatment …

3rd Annual Meeting, Genoa June 2025 Read More »

ISSAID, Paris April 2025

ISSAID is the 13th Meeting of the International Society of Sistemic Auto-Inflamamtory Diseases. The Congress will take place at the Cité Internationale Universitaire de Paris, France, 8-10 April 2025. Key Topics of the Conference: We have already submitted 3 abstracts concerning the PerSAIDs project.

EP PerMed Conference, Berlin February 2025

ERA PerMed JTC2021 Midterm Symposium – Advancing Clinical Support Tools for Personalised Medicine The symposium brought together researchers, clinicians, funders and patient representatives to discuss the progress and outcomes of the ERA PerMed projects and featured presentations from 21 interdisciplinary consortia funded under the JTC2021 call, which focuses on the development of clinical support tools to …

EP PerMed Conference, Berlin February 2025 Read More »

Video competition for young researchers of ERA PerMed’s Joint Transnational Calls 2019-2021 on personalised medicine

We are engaged in groundbreaking collaborative research in the field of personalised medicine, working alongside international teams. Purpose: The purpose of the EP PerMed Video Competition is to prepare a short video for general audience, showcasing our consortium’s research project, the multi-national collaboration, the aims and results we achieved, the unique methods or technology used and …

Video competition for young researchers of ERA PerMed’s Joint Transnational Calls 2019-2021 on personalised medicine Read More »

Aim and Composition of the Project

SAIDs are a growing number of rare conditions (monogenic or multifactorial), secondary to disregulation of mechanisms controlling innate immune responses and characterized by sterile inflammation.For monogenic SAID, personalised medicine is already a consolidated reality; however new evidence suggests that even undefined SAID could benefit from this approach.The PerSAIDs Project aims to:-link together the larger SAID …

Aim and Composition of the Project Read More »

PerSAIDs

Multidisciplinary research project on personalised medicine –Development of clinical support tools for personalised medicine implementationin SAIDs (Systemic Auto-Inflammatory Diseases)

ISSAID, Toronto May 2023

ISSAID 2023, 15-18 May, Toronto, CanadaPosterPredicting the Probability of FMF for Patients with Autoinflammatory Diseases by Using Machine Learning: First Insights from the PerSAIDs ProjectAyoub Abid, Fuat Akal, Ezgi Deniz Batu, Silvia Federici, Camilla Speziani, Francesca Bovis, Roberta Caorsi, Seher Sener, Nicola Ruperto, Isabella Ceccherini, Marco Gattorno, Seza Ozen

1st Annual Meeting, Camogli October 2023

During the first 18 months there was a fruitful and active synergy between the partners to ensure the smooth development of all aspects of the project, with clinical activities, infrastructure configuration and analysis having to take place in parallel.In particular, the recruitment of samples and retrospective data saw a solid collaboration between the clinical centers, …

1st Annual Meeting, Camogli October 2023 Read More »